• 제목/요약/키워드: Antiinflammatory

검색결과 500건 처리시간 0.028초

HPLC에 의한 뱀장어 (Anguilla japonica) 혈장중의 acethylsalicylic acid (aspirin)과 salicylic acid의 측정 (Determination of Acethylsalicylic acid (Aspirin) and Salicylic acid in Eel (Anguilla japonica) Plasma by High-performance Liquid Chromatography)

  • 김동완;구재근;박성우
    • 한국어병학회지
    • /
    • 제20권2호
    • /
    • pp.139-145
    • /
    • 2007
  • 인체에 널리 사용되고 있는 Aspirin (ASA)을 양식 뱀장어 (Anguilla japonica) 약욕 또는 경구 투여한 다음 혈장 중의 ASA와 salicylic acid (SA)의 양을 HPLC로 측정하였다. 뱀장어 혈장은 0.2 M HCl과 0.2 M orthophosphoric acid로 산성화시킨 다음 acetonitrile과 혼합하여 ASA와 SA를 추출하였다. 2약제의 정량은 Novapak C18과 UV detector (237 nm)가 장착된 HPLC로 측정하였다. 이 때 이동상은 740 ㎖의 증류수, 900 ㎕의 orthophosphoric acid와 180㎖의 acetonitrile을 사용하였다. ASA, SA 및 내부 표준물질로 사용한 2-methylbenzoic acid (MBA)의 retention time은 각각 4.8분, 8.4분 및 11.4분이였으며, 측정한계 농도는 ASA가 0.05 ㎍/㎖, SA는 0.01 ㎍/㎖였다. 혈장으로 부터의 평균회수율은 ASA가 70.8-99.6%, SA는 95.2-100.3%였다. 뱀장어에 ASA를 약욕 (20 ppm) 또는 경구투여 (50 ㎎/kg BW) 한 다음 채취한 혈장을 시료로 이 방법으로 ASA와 SA의 양을 측정한 결과 단지 SA만 검출되어졌고, ASA는 검출되지 않았다. 이는 ASA가 혈장내에서 신속히 SA로 분해되기 때문으로 판명되었다. 또 ASA에 약욕시킨 경우에는 약욕 후 3시간후에 혈장내의 SA양이 최고치에 도달하였으며, 경구투여 한 경우에는 7일후에 최고치에 도달하였다. 한편 ASA를 투여한 다음 ASA 무첨가 수조에 수용한 결과 2투여 경로 모두 48시간 이후에는 SA가 0.02-0.03 ㎍/㎖이 검출되어 잔류의 문제도 거의 없었다. HPLC를 이용한 혈장내의 ASA와 SA의 검출법은 신속하며 정확한 방법으로 뱀장어 이외의 어류에도 활용 가능할 것으로 생각된다.

Upregulation of Lipopolysaccharide-Induced Interleukin-10 by Prostaglandin $A_1$ in Mouse Peritoneal Macrophages

  • Kim, Hyo-Young;Kim, Jae-Ryong;Kim, Hee-Sun
    • Journal of Microbiology and Biotechnology
    • /
    • 제18권6호
    • /
    • pp.1170-1178
    • /
    • 2008
  • The cyclopentenone prostaglandins (cyPGs) prostaglandin $A_1$ ($PGA_1$) and 15-deoxy-${\Delta}^{12,14}$-prostaglandin $J_2$ (15d-$PGJ_2$) have been reported to exhibit antiinflammatory activity in activated monocytes/macrophages. However, the effects of these two cyPGs on the expression of cytokine genes may differ. In this study, we investigated the mechanism of action of $PGA_1$ in lipopolysaccharide (LPS)-induced expression of inter leu kin (IL)-10 mRNA in mouse peritoneal macrophages. 15d-$PGJ_2$ inhibited expression of LPS-induced IL-10, whereas $PGA_1$ increased LPS-induced IL-10 expression. This synergistic effect of $PGA_1$ on LPS-induced IL-10 expression reached a maximum as early as 2 h after simultaneous $PGA_1$ and LPS treatment ($PGA_1$/LPS), and did not require new protein synthesis. The synergistic effect of $PGA_1$ was inhibited by GW9662, a specific peroxisome proliferator-activated receptor ${\gamma}(PPAR{\gamma})$ antagonist, and Bay-11-7082, a NF-${\kappa}B$ inhibitor. The extracellular signal-regulated kinases (ERK) inhibitor PD98059 increased the expression of $PGA_1$/LPS-induced IL-10 mRNA, rather than inhibiting the IL-10 expression. Moreover, $PGA_1$ inhibited LPS-induced ERK phosphorylation. The synergistic effect of $PGA_1$ on LPS-induced IL-10 mRNA and protein production was inhibited by p38 inhibitor PD169316, and $PGA_1$ increased LPS-induced p38 phosphorylation. In the case of stress-activated protein kinase/c-Jun $NH_2$-terminal kinase (SAPK/JNK), the SAPK/JNK inhibitor SP600125 did not inhibit IL-10 mRNA synthesis but inhibited the production of IL-10 protein remarkably. These results suggest that the synergistic effect of $PGA_1$ on LPS-induced IL-10 expression is NF-${\kappa}B$-dependent and mediated by mitogen-activated protein (MAP) kinases, p38, and SAPK/JNK signaling pathways, and also associated with the $PPAR{\gamma}$ pathway. Our data may provide more insight into the diverse mechanisms of $PGA_1$ effects on the expression of cytokine genes.

아세클로페낙의 경피 제제설계 및 피부투과 특성 (Formulation and Skin Penetration Characteristics of Aceclofenac Plaster for Transdermal Delivery)

  • 정종근;이민석;박정화;이장원;김하형;최영욱;이광표
    • Journal of Pharmaceutical Investigation
    • /
    • 제29권1호
    • /
    • pp.29-36
    • /
    • 1999
  • Aceclofenac is an non-steroidal antiinflammatory drug which has been used in the treatment of rheumatoidal rthritis and osteo-arthritis. In order to decrease the gastric ulcerogenic effects and contol the plasma level of aceclofenac, we have developed the transdermal delivery system of aceclofenac plaster, which were formulated employing matrix polymers of acrylates and penetration-enhancers such as $Lauroglycol^{\circledR}$, $Transcutol^{\circledR}$, oleic acid and linoleic acid. Using Franz diffusion cells mounted with a rat skin, transdermal penetration characteristics of the formulations were evaluated by the HPLC assay of aceclofenac and diclofenac, an active metabolite, in the receptor compartment of pH 7.2 phosphate buffered solution. Skin penetration was increased when the content of aceclofenac increased, showing the flux $(J,\;{\mu}g/cm^2/hr)$ of 0.37 and 2.50 for 2% and 6.75% of the content, respectively. The flux$(J,\;{\mu}g/cm^2/hr)$ from plasters made of $Durotak^{\circledR}$ 87-2074, $Durotak^{\circledR}$ 87-2510 and $Durotak^{\circledR}$ 87-2097 were 2.50, 2.77 and 4.39, respectively. $Durotak^{\circledR}$ 87-2074 showed the lowest penetration due to the carboxylic acid group in the polymer, which might form a strong hydrogen bonding with a secondary amine of aceclofenac. Although both $Durotak^{\circledR}$ 87-2510 and $Durotak^{\circledR}$ 87-2097 are amine-resistant adhesives, $Durotak^{\circledR}$ 872510 showed lower penetration than $Durotak^{\circledR}$ 87-2097 because of the hydroxyl group in $Durotak^{\circledR}$ 87-2510, which might form a weak hydrogen bonding with aceclofenac. These results reveal that the functional group in acrylic polymers would greatly affect the release of aceclofenac from the matrix, which is the rate-limiting step in the penetration of aceclofenac through rat skins. The penetration of aceclofenac from plasters using different penetration-enhancers increased in the following order: Transcutol < linoleic acid < oleic acid. And the flux from the plasters containing oleic acid as a penetrationenhancer was 2.22 times greater than that of creams, which suggest that a newly deveolped aceclofenac plaster could be used in the treatment of rheumatoidal arthritis and osteo-arthritis as an advanced transdermal delivery system.

  • PDF

Ischemia에 의해 유발된 흰쥐의 적출 심장 손상에 대한 Cyclobuxine D의 보호효과 (Effects of Cyclobuxine D on the Derangement Induced by Ischemia and Reperfusion in the Isolated Rat Heart)

  • 이종화;문창규;권준택;조병헌;김유재;김종배;김창호;차영덕;김영석
    • 대한약리학회지
    • /
    • 제26권1호
    • /
    • pp.7-12
    • /
    • 1990
  • 흰쥐로 부터 심장을 적출하여 Langendorff 관류장치에 현수하여 Krebs-Hensleit 영양액으로 분당 12ml속도로 30분간 관류시킨 후 관류 속도를 분당 1ml로 줄여(ischemia)60분간 관류시키면, 적출심장의 수축력이 현저히 감소되었고, resting tension이 현저히 증가되었다. 또 적출심장으로부터 유출되는 관류액의 250nm에서의 UV흡광치는 증가되었으며, 좌심실내의 칼슘의 농도는 대조군보다 상당히 증가되었다. 본 실험에서는 흰쥐에서 항염증작용, 혈압강하 및 서맥 작용, 평활근 및 심장근에서 근이완작용을 나타내는 cyclobuxine D의 ischemia에 의해 유도된 심장손상에 대한 보호효과를 관찰하였다. Cyclobuxine D(100ng/ml)는 ischemia에 의해 유발된 적출심장의 수축력 감소와 resting tension의 증가를 유의하게 억제하였으며, 심장으로부터의 ATP metabolites의 유출과 좌심실내의 칼슘 축적을 억제시켰다. 이상의 결과는 Cyclobuxine D가 ischemia에 의해 유발된 손상으로 부터 심장을 보호할 수 있음을 나타내며, 이는 cyclobuxine D의 심장세포내의 칼슘 유입 억제작용에 기인하는 것으로 사려된다.

  • PDF

NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)에 의한 사람 중성구 Cathepsin G의 활성도 억제 (Inhibition of Human Leukocyte Cathepsin G by NSAIDs (Non-Steroidal Anti-Inflammatory Drugs))

  • 배성준;감사열;강구일
    • 대한약리학회지
    • /
    • 제26권1호
    • /
    • pp.51-54
    • /
    • 1990
  • 사람 중성구내의 azurophil granule 내에 존재하는 serine protease인 cathepsin G는 정상 반응에서는 항 박테리아 작용을 나타내는데 관여하지만, 이들의 효소활성이 비정상적으로 증가되었을 때는 오히려 인체 정상 조직을 파괴함으로써 rheumatoid arthritis를 비롯한 여러가지 염증성 질환을 야기시킨다고 알려져 있다. 항염증제로 작용하는데 있어서 prostaglandin 합성을 억제하는 작용 이외에 다른 작용 기전이 있는가 하는것은 대단히 흥미있는 연구 과제이었으므로 neutral protease 중의 하나인 cathepsin G와 이 염증반응에 직접적으로 관여하는지 알아보기 위하여 본 연구에서는 두 단계의 크로마토그라피를 거쳐 순수한 cathepsin G를 분리하고, 여러가지 비스테로이드성 항염증제를 이용하여 cathepsin G에 대한 억제 정도를 관찰하였다. 이중 sulindac, salicylate, phenylbutazone, oxyphenbutazone 그리고 salicyluric acid가 각각 4.3mM, 14.3mM, 6.5mM, 11mM, 15mM의 $IC_{50}$로써 cathepsin G의 활성도를 억제하였다. 따라서 NSAIDs의 항염증 작용 기전은 기존에 알려지고 있는 cyclooxygenase 억제에 따른 prostaglanndin 합성, 분비 억제 기전이외에 rheumatoid arthritis 부위에 직접적 원인으로 작용할 가능성이 있는 cathepsin G를 억제 함으로써 조직 파괴를 막는 역할을 하고 있을 가능성이 있는 것으로 사료된다.

  • PDF

NecroX-5 exerts anti-inflammatory and anti-fibrotic effects via modulation of the TNFα/Dcn/TGFβ1/Smad2 pathway in hypoxia/reoxygenation-treated rat hearts

  • Thu, Vu Thi;Kim, Hyoung Kyu;Long, Le Thanh;Thuy, To Thanh;Huy, Nguyen Quang;Kim, Soon Ha;Kim, Nari;Ko, Kyung Soo;Rhee, Byoung Doo;Han, Jin
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제20권3호
    • /
    • pp.305-314
    • /
    • 2016
  • Inflammatory and fibrotic responses are accelerated during the reperfusion period, and excessive fibrosis and inflammation contribute to cardiac malfunction. NecroX compounds have been shown to protect the liver and heart from ischemia-reperfusion injury. The aim of this study was to further define the role and mechanism of action of NecroX-5 in regulating inflammation and fibrosis responses in a model of hypoxia/reoxygenation (HR). We utilized HR-treated rat hearts and lipopolysaccharide (LPS)-treated H9C2 culture cells in the presence or absence of NecroX-5 ($10{\mu}mol/L$) treatment as experimental models. Addition of NecroX-5 significantly increased decorin (Dcn) expression levels in HR-treated hearts. In contrast, expression of transforming growth factor beta 1 ($TGF{\beta}1$) and Smad2 phosphorylation (pSmad2) was strongly attenuated in NecroX-5-treated hearts. In addition, significantly increased production of tumor necrosis factor alpha ($TNF{\alpha}$), $TGF{\beta}1$, and pSmad2, and markedly decreased Dcn expression levels, were observed in LPS-stimulated H9C2 cells. Interestingly, NecroX-5 supplementation effectively attenuated the increased expression levels of $TNF{\alpha}$, $TGF{\beta}1$, and pSmad2, as well as the decreased expression of Dcn. Thus, our data demonstrate potential antiinflammatory and anti-fibrotic effects of NecroX-5 against cardiac HR injuries via modulation of the $TNF{\alpha}/Dcn/TGF{\beta}1/Smad2$ pathway.

Antinociceptive and anti-inflammatory effects of ginsenoside Rf in a rat model of incisional pain

  • Kim, Min Kyoung;Kang, Hyun;Baek, Chong Wha;Jung, Yong Hun;Woo, Young Cheol;Choi, Geun Joo;Shin, Hwa Yong;Kim, Kyung Soo
    • Journal of Ginseng Research
    • /
    • 제42권2호
    • /
    • pp.183-191
    • /
    • 2018
  • Background: Ginseng saponin has long been used as a traditional Asian medicine and is known to be effective in treating various kinds of pain. Ginsenoside Rf is one of the biologically active saponins found in ginseng. We evaluated ginsenoside Rf's antinociceptive and anti-inflammatory effects, and its mechanism of action on adrenergic and serotonergic receptors, in an incisional pain model. Methods: Mechanical hyperalgesia was induced via plantar incision in rats followed by intraperitoneal administration of increasing doses of ginsenoside Rf (vehicle, 0.5 mg/kg, 1 mg/kg, 1.5 mg/kg, and 2 mg/kg). The antinociceptive effect was also compared in a Positive Control Group that received a ketorolac (30 mg/kg) injection, and the $Na{\ddot{i}}ve$ Group, which did not undergo incision. To evaluate the mechanism of action, rats were treated with prazosin (1 mg/kg), yohimbine (2 mg/kg), or ketanserin (1 mg/kg) prior to receiving ginsenoside Rf (1.5 mg/kg). The mechanical withdrawal threshold was measured using von Frey filaments at various time points before and after ginsenoside Rf administration. To evaluate the anti-inflammatory effect, serum interleukin $(IL)-1{\beta}$, IL-6, and tumor necrotizing $factor-{\alpha}$ levels were measured. Results: Ginsenoside Rf increased the mechanical withdrawal threshold significantly, with a curvilinear dose-response curve peaking at 1.5 mg/kg. $IL-1{\beta}$, IL-6, and tumor necrotizing $factor-{\alpha}$ levels significantly decreased after ginsenoside Rf treatment. Ginsenoside Rf's antinociceptive effect was reduced by yohimbine, but potentiated by prazosin and ketanserin. Conclusion: Intraperitoneal ginsenoside Rf has an antinociceptive effect peaking at a dose of 1.5 mg/kg. Anti-inflammatory effects were also detected.

탁리소독음(托裏消毒飮) 합(合) 황련해독탕(黃連解毒湯)의 아토피피부염에 대한 실험적 연구 (Effect of Taklisodok-um and Hwangryunhaedok-tang on Atopic Dermatitis)

  • 원영호;황충연;임규상;김종한;고성규;이부균;이동효;김남권
    • 한방안이비인후피부과학회지
    • /
    • 제24권1호
    • /
    • pp.121-141
    • /
    • 2011
  • Objective : This Experimental study was done to investigate the Effect of Taklisodok-um and Hwangryunhaedok-tang(TH) on Atopic Dermatitis. Methods : We assessed effects of TH on the IgE, IL-4, IL-5, IL-6, IgM, IgG1, IFN-${\gamma}$ in vivo, on the IL-4, IL-5, CCR3 in the skin tissues of ear and dorsum with NC/Nga mice. And we assessed effects of TH on the COX-2, IL-$1{\beta}$, TNF-${\alpha}$, IL-6 with RAW 264.7 cell. Results and Conclusion : 1. IgE, IL-4, IL-5, IL-6, IgM, IgGl levels in the serum of TH treated NC/Nga mouse group were decreased compared to the untreated control mice. IFN-r showed a increase in the experimental group compared to the untreated control group. The spleen weight of TH treated NC/Nga mice was decreased compared to the untreated control group. 2. mRNA expression levels of IL-4, IL-5 and CCR3 in the skin tissues of TH treated NC/Nga mice were decreased, and expression levels of IL-6 in the skin tissues of TH treated NC/Nga mice were decreased compared to the untreated control group. IFN-${\gamma}$ mRNA expression levels were increased compared to the untreated control group. 3. Judged from that IL-$1{\beta}$, TNF-${\alpha}$, IL-6 express of gene, effect of inflammatory Cytokines revelation were decreased compared to the untreated control group. 4. Depend on the strength of TH, inflammatory RAW 264.7 in the serum of TH were inhibited compared to the untreated control serum that leaded a COX-2 activity model. 5. Histological observation of the ear and skin tissues showed that the extents of inflammation and infiltrated immune cells in the epidermis and dermis of TH treated NC/Nga mice were highly reduced compared to the untreated control group.

감귤 과피의 페놀성 화합물 함량과 항산화 활성 (Phenolic Compound Content and Antioxidant Activity of Citrus Peels)

  • 황준호;박경열;오유성;임상빈
    • 한국식품영양과학회지
    • /
    • 제42권2호
    • /
    • pp.153-160
    • /
    • 2013
  • 감귤 7종을 대상으로 과피를 80% 메탄올로 추출하여 총페놀과 총플라보노이드 함량을 측정하였고, 유해산소 흡수능력(ORAC) 분석을 통한 free radical 소거능, RAW 264.7 murine macrophage를 이용한 NO 생성 저해능, LPS와 t-BHP 자극에 의한 활성산소 생성 저해 활성을 분석하였다. 총페놀 함량은 영귤, 천혜향, 진귤이 각각 30.6, 30.2, 28.2 mg GAE/g으로 높은 값을 나타내었고, 총플라보노이드 함량은 영귤과 진귤이 각각 30.3와 25.5 mg RE/g으로 높은 값을 나타내었다. ORAC 분석을 통한 free radical 소거능은 영귤이 1076 mM TE/g으로 가장 높은 활성을 나타내었으며, 그 다음이 천혜향(1012), 진귤(984), 한라봉(914) 순이었다. 마우스 대식세포인 RAW 264.7에 의한 NO 생성 저해능 ($IC_{50}$)은 천혜향이 215.3 ${\mu}g/mL$로 가장 높았으며, 그 다음으로 영귤(259.2), 진귤(328.9) 순이었다. LPS 자극에 의한 활성산소 생성은 한라봉이 16.4%, 진귤이 12.8% 저해하였고, t-BHP 자극에 의한 활성산소 생성은 진귤, 한라봉, 천혜향이 각각 28.7, 26.1, 26.6% 저해하였다. 총페놀과 ORAC 간의 상관계수는 0.884이고 총플라보노이드와 ORAC 간의 상관계수는 0.855로, ORAC에 의한 항산화 활성은 총페놀 및 총플라보노이드의 함량과 밀접한 관계가 있는 것으로 나타났다. 총페놀 및 총플라보노이드 함량과 NO 생성 저해능 간의 상관계수는 각각 0.921과 0.683으로 NO 생성 저해능도 총페놀 및 총플라보노이드 함량과 밀접한 관계가 있었다.

비스테로이드소염제로 인한 궤양 합병증 예방을 위한 비스테로이드소염제 사용 현황 및 적절성 평가 (Evaluation of NSAID Usage and Appropriateness for Prevention of NSAID-Related Ulcer Complications)

  • 조정원;이은숙;신완균
    • 한국임상약학회지
    • /
    • 제22권3호
    • /
    • pp.211-219
    • /
    • 2012
  • Nonsteroidal antiinflammatory drugs (NSAIDs) are used in the treatment of extensive diseases related to various symptoms; inflammation, pain and fever. NSAIDs work by blocking prostaglandin synthesis, but adverse drug events (ADEs) have been increasing dramatically such as gastrointestinal bleeding, perforation and stenosis, a kind of serious ADEs. Therefore, NSAID-related ulcer complication guidelines have been announced containing various risk factors and symptoms. Thus, this study aims to evaluate of NSAID usage and appropriateness for prevention of NSAID-related ulcer complication based on American journal of gastroenterology (AJG) guideline 2009. Further, the study suggests Korean guideline for prevention of NSAID-related ulcer compared to AJG guideline. For this study, data was collected through electronic medical record (EMR) at Seoul national university of Bundang hospital. The primary end point was a composite of NSAID-related ulcer risk factor, types of NSAIDs, co-prescribed NSAID ulcer prevention drugs and NSAID-related ulcer after taking NSAID. The risk factors include over 65 years, high dose NSAID, previous ulcer history and taking drugs (e.g. aspirin, anticoagulant and steroid) causing ulcer. If a patient has 3 or 4 factors, that patient was classified high risk group. And if 1 or 2 factors that patient was classified moderate risk group. The patient who has no risk factor was in low risk group. I studied 8,120 patients who received NSAID from 1 January 2009 to 31 December 2009. High risk group was 16(0.2%), moderate risk group was 4,364(53.7%), and low risk group was 3,740(46.1%). The results show that high risk group should be prescribed COX-2 inhibitors with ulcer prevention drugs, and moderate or low risk group need traditional NSAIDs with ulcer prevention drugs. This may be different with 2009 AJG guideline because AJG guideline suggested taking COX-2 inhibitor alone in moderate group or taking traditional NSAID alone in low risk group could get higher ulcer complication. The results indicated that choosing preventive drug is important in case that how many risk factors the patients have. The proper drugs would be helpful for safe and effective NSAID usage in each patient group.